Karyopharm Therapeutics Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2013 | $-5.59 | $-11.36 |
| FY2014 | $-2.43 | $-9.32 |
| FY2015 | $-3.32 | $-8.34 |
| FY2016 | $-2.92 | $-7.59 |
| FY2017 | $-2.81 | $-7.02 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2013 | $-5.59 | $-11.36 |
| FY2014 | $-2.43 | $-9.32 |
| FY2015 | $-3.32 | $-8.34 |
| FY2016 | $-2.92 | $-7.59 |
| FY2017 | $-2.81 | $-7.02 |